Cas 202931-59-7,(±)-ethyl 4-methyl-2-(((trifluoromethyl)sulfonyl)oxy)cyclohex-1-enecarboxylate

202931-59-7

Post Buying Request

Basic information

Product Name: (±)-ethyl 4-methyl-2-(((trifluoromethyl)sulfonyl)oxy)cyclohex-1-enecarboxylate
Synonyms: (±)-ethyl 4-methyl-2-(((trifluoromethyl)sulfonyl)oxy)cyclohex-1-enecarboxylate
CAS NO:202931-59-7
Molecular Formula:
Molecular Weight: 316.298
EINECS: N/A
Product Categories: N/A
Mol File: 202931-59-7.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (±)-ethyl 4-methyl-2-(((trifluoromethyl)sulfonyl)oxy)cyclohex-1-enecarboxylate(CAS DataBase Reference)
NIST Chemistry Reference: (±)-ethyl 4-methyl-2-(((trifluoromethyl)sulfonyl)oxy)cyclohex-1-enecarboxylate(202931-59-7)
EPA Substance Registry System: (±)-ethyl 4-methyl-2-(((trifluoromethyl)sulfonyl)oxy)cyclohex-1-enecarboxylate(202931-59-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 202931-59-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

202931-59-7 Suppliers

Recommended suppliersmore

202931-59-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 202931-59-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,2,9,3 and 1 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 202931-59:
(8*2)+(7*0)+(6*2)+(5*9)+(4*3)+(3*1)+(2*5)+(1*9)=107
107 % 10 = 7
So 202931-59-7 is a valid CAS Registry Number.

202931-59-7Upstream product

202931-59-7Downstream Products

202931-60-0 1-Ethyl-2-methyl 4-methylcyclohex-1-ene-1,2-dicarboxylate

202931-59-7Relevant articles and documents

CYCLOHEXEN-1-YL-PYRIDIN-2-YL-1H-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

-

Page/Page column 52, (2016/02/28)

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacolo

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 202931-59-7